Abstract
Microglial cells respond to the herpes simplex virus (HSV)-1 by producing proinflammatory cytokines and chemokines. After this inflammatory burst, these cells undergo apoptotic cell death. We have recently demonstrated that both virus-induced immune mediator production and apoptosis were induced through Toll-like receptor 2 (TLR2) signaling. Based upon these findings, we hypothesized that the inhibition of TLR2 signaling may serve as a means to alleviate excessive neuroinflammation. In the present study, we cloned four vaccinia virus (VV) proteins, which have been reported to disrupt either TLR signaling or NF-kappaB activation, and overexpressed them in HEK293T cells stably expressing murine TLR2 and in primary murine microglia. Using an NF-kappaB-driven luciferase reporter gene assay, we show that upon stimulation with HSV and Listeria monocytogenes, all four vaccinia proteins inhibited TLR2 signaling with different levels of inhibition in the TLR2-expressing cell line and primary microglia. We found similar results when microglial cells were stimulated with the TLR4 ligand LPS and the TLR9 ligand CpG ODN. Taken together, these data provide evidence that these VV proteins can function as inhibitors of TLR signaling in primary microglial cells.
MeSH Terms
Animals
DNA/pharmacology
Enzyme Activation/physiology
Herpesvirus 1, Human/physiology
Lipopolysaccharides/pharmacology
Listeria monocytogenes/physiology
Mice
Mice, Knockout
Microglia/metabolism,virology
NF-kappa B/metabolism
Oligodeoxyribonucleotides
Polymerase Chain Reaction
Signal Transduction/physiology
Toll-Like Receptors/metabolism
Transfection
Vaccinia virus/genetics,physiology
Viral Proteins/genetics,metabolism
Chemicals
CpG ODN 1826
Lipopolysaccharides
NF-kappa B
Oligodeoxyribonucleotides
Toll-Like Receptors
Viral Proteins
DNA
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Aravalli Rajagopal N
Neuroimmunology Laboratory, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, 2001 6th Street SE, Minneapolis, MN 55455, USA.
Hu Shuxian
Lokensgard James R
References (22)
22 references, click to expand
-
Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1.
J Neurovirol. 2006 Dec;12(6):501-10
PMID: 17162665
-
Toll-like receptors in defense and damage of the central nervous system.
J Neuroimmune Pharmacol. 2007 Dec;2(4):297-312
PMID: 18040848
-
Microglia and neuroinflammation: a pathological perspective.
J Neuroinflammation. 2004 Jul 30;1(1):14
PMID: 15285801
-
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7
PMID: 10920188
-
Anti-immunology: evasion of the host immune system by bacterial and viral pathogens.
Cell. 2006 Feb 24;124(4):767-82
PMID: 16497587
-
Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11416-21
PMID: 15272082
-
Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia.
Glia. 2004 Sep;47(4):358-66
PMID: 15293233
-
Pathogen recognition and innate immunity.
Cell. 2006 Feb 24;124(4):783-801
PMID: 16497588
-
Toll-like receptor 2 is required for optimal control of Listeria monocytogenes infection.
Infect Immun. 2004 Apr;72(4):2131-9
PMID: 15039335
-
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
J Exp Med. 2005 Mar 21;201(6):1007-18
PMID: 15767367
-
Immune function of microglia.
Glia. 2001 Nov;36(2):165-79
PMID: 11596125
-
Viral mimicry of cytokines, chemokines and their receptors.
Nat Rev Immunol. 2003 Jan;3(1):36-50
PMID: 12511874
-
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.
Blood. 2004 Feb 15;103(4):1433-7
PMID: 14563635
-
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1315-20
PMID: 14739339
-
TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker.
J Immunol. 2005 May 15;174(10):6467-76
PMID: 15879150
-
Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus.
J Immunol. 2005 Oct 1;175(7):4189-93
PMID: 16177057
-
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.
J Exp Med. 2003 Feb 3;197(3):343-51
PMID: 12566418
-
Immunostimulatory CpG-DNA activates murine microglia.
J Immunol. 2002 May 15;168(10):4854-63
PMID: 11994434
-
Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization.
J Biol Chem. 2005 Jan 14;280(2):1678-87
PMID: 15522867
-
The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
J Virol. 2004 Apr;78(7):3553-60
PMID: 15016878
-
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
J Biol Chem. 2004 Aug 27;279(35):36570-8
PMID: 15215253
-
Neuroprotective role of IL-4 against activated microglia.
J Immunol. 1993 Aug 1;151(3):1473-81
PMID: 8335941